Lars Jenicke

1.0k total citations
23 papers, 772 citations indexed

About

Lars Jenicke is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Lars Jenicke has authored 23 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Otorhinolaryngology. Recurrent topics in Lars Jenicke's work include Effects of Radiation Exposure (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Medical Imaging Techniques and Applications (4 papers). Lars Jenicke is often cited by papers focused on Effects of Radiation Exposure (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Medical Imaging Techniques and Applications (4 papers). Lars Jenicke collaborates with scholars based in Germany, China and United States. Lars Jenicke's co-authors include Norbert Avril, K. H. Bohuslavizki, F. Jänicke, M. Clausen, Joerg Schwarz, M. Bader, Ralph Buchert, Christian R. Habermann, Winfried Brenner and Jost Obrocki and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Movement Disorders.

In The Last Decade

Lars Jenicke

22 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Jenicke Germany 11 396 238 159 147 138 23 772
Xiangyu Sun China 15 124 0.3× 248 1.0× 352 2.2× 190 1.3× 216 1.6× 54 1.0k
Changli Lu China 16 65 0.2× 44 0.2× 135 0.8× 107 0.7× 101 0.7× 40 679
Rong Yu China 13 57 0.1× 258 1.1× 143 0.9× 181 1.2× 67 0.5× 84 682
Francesco Barbato Italy 14 181 0.5× 212 0.9× 50 0.3× 46 0.3× 28 0.2× 40 438
Hideyuki Maeda Japan 10 27 0.1× 149 0.6× 91 0.6× 19 0.1× 8 0.1× 42 340
Michelle Roytman United States 13 116 0.3× 83 0.3× 114 0.7× 44 0.3× 17 0.1× 41 545
John Mangiardi United States 14 25 0.1× 87 0.4× 139 0.9× 41 0.3× 23 0.2× 20 481
Ngoc Nguyen Germany 13 414 1.0× 196 0.8× 132 0.8× 14 0.1× 18 0.1× 19 905
Erkan İbiş Türkiye 13 99 0.3× 107 0.4× 126 0.8× 80 0.5× 23 0.2× 34 374
Stephanie K A Blick New Zealand 8 64 0.2× 39 0.2× 60 0.4× 105 0.7× 12 0.1× 10 408

Countries citing papers authored by Lars Jenicke

Since Specialization
Citations

This map shows the geographic impact of Lars Jenicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Jenicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Jenicke more than expected).

Fields of papers citing papers by Lars Jenicke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Jenicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Jenicke. The network helps show where Lars Jenicke may publish in the future.

Co-authorship network of co-authors of Lars Jenicke

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Jenicke. A scholar is included among the top collaborators of Lars Jenicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Jenicke. Lars Jenicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jenicke, Lars, et al.. (2008). Detection of metastases in breast cancer patients. Nuklearmedizin - NuclearMedicine. 47(3). 97–103. 6 indexed citations
3.
Lewerenz, Jan, Bartosz Zurowski, Lars Jenicke, et al.. (2005). Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy. Movement Disorders. 20(8). 1071–1075. 2 indexed citations
4.
Schwarz, Joerg, et al.. (2005). Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.. PubMed. 46(7). 1144–50. 170 indexed citations
5.
Wenzel, S., et al.. (2004). Sodium selenite is a potent radioprotector of the salivary glands of the rat: acute effects on the morphology and parenchymal function during fractioned irradiation. European Archives of Oto-Rhino-Laryngology. 262(6). 459–464. 5 indexed citations
6.
Wenzel, S., et al.. (2004). Reduktion akuter radiogener Schädigungen durch Natriumselenit. HNO. 52(12). 1067–1075. 4 indexed citations
7.
8.
Wenzel, S., et al.. (2003). Investigation of radiosialadenitis during fractioned irradiation: sialoscintigraphical and histomorphological findings in rats. European Archives of Oto-Rhino-Laryngology. 260(9). 513–517. 17 indexed citations
9.
Rohde, Holger, Matthias A. Horstkotte, Jens Aberle, et al.. (2003). Recurrent Listeria monocytogenes aortic graft infection: confirmation of relapse by molecular subtyping. Diagnostic Microbiology and Infectious Disease. 48(1). 63–67. 26 indexed citations
10.
Wenzel, S., Lars Jenicke, K. H. Bohuslavizki, et al.. (2002). Reduktion der Spättoxizität durch Amifostin bei fraktionierter Bestrahlung der Rattenspeicheldrüsen. HNO. 50(9). 822–828. 8 indexed citations
11.
Zywietz, F., et al.. (2002). Multiple Application of Drugs in Rats – a New Port System. Oncology Research and Treatment. 25(2). 178–180. 7 indexed citations
12.
Dose, J., Stephan Bachmann, K. H. Bohuslavizki, et al.. (2002). Comparison of fluorodeoxyglucose positron emission tomography and ‘conventional diagnostic procedures’ for the detection of distant metastases in breast cancer patients. Nuclear Medicine Communications. 23(9). 857–864. 76 indexed citations
13.
Jenicke, Lars, Susanne Klutmann, K. H. Bohuslavizki, et al.. (2001). Conventional staging and 18 F-FDG-PET staging of malignant melanoma. Radiology and Oncology. 35(2). 2 indexed citations
14.
Jenicke, Lars, et al.. (2001). Artifacts and non-osseous uptake in bone scintigraphy. Imaging reports of 20 cases. Radiology and Oncology. 35(3). 9 indexed citations
15.
Fritscher‐Ravens, Annette, K. H. Bohuslavizki, Dieter C. Bröering, et al.. (2001). FDG PET in the diagnosis of hilar cholangiocarcinoma. Nuclear Medicine Communications. 22(12). 1277–1285. 106 indexed citations
16.
Buchert, Ralph, Jost Obrocki, Rainer Thomasius, et al.. (2001). Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET. Nuclear Medicine Communications. 22(8). 889–897. 56 indexed citations
17.
Jenicke, Lars, et al.. (2001). [FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports].. PubMed. 40(4). N35–8.
18.
Klutmann, Susanne, et al.. (2001). Prevalence of iodine- and thyroglobulin negative findings in differentiated thyroid cancer. Nuklearmedizin - NuclearMedicine. 40(5). 143–147. 5 indexed citations
19.
Bohuslavizki, K. H., Susanne Klutmann, Lars Jenicke, et al.. (1999). Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model. International Journal of Radiation Oncology*Biology*Physics. 45(1). 181–186. 29 indexed citations
20.
Bohuslavizki, K. H., Susanne Klutmann, Lars Jenicke, et al.. (1999). Salivary Gland Protection by S-2-(3-aminopropylamino)-ethylphosphorothioic Acid (amifostine) in High-dose Radioiodine Treatment: Results Obtained in a Rabbit Animal Model and in a Double-blind Multi-arm Trial. Cancer Biotherapy and Radiopharmaceuticals. 14(5). 337–347. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangyu Sun Breakdown of academic impact, for papers by Changli Lu Breakdown of academic impact, for papers by Rong Yu Breakdown of academic impact, for papers by Francesco Barbato Breakdown of academic impact, for papers by Hideyuki Maeda Breakdown of academic impact, for papers by Michelle Roytman Breakdown of academic impact, for papers by John Mangiardi Breakdown of academic impact, for papers by Ngoc Nguyen Breakdown of academic impact, for papers by Erkan İbiş Breakdown of academic impact, for papers by Stephanie K A Blick
Rankless by CCL
2026